| __timestamp | Bristol-Myers Squibb Company | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 15879000000 | 580415000 |
| Thursday, January 1, 2015 | 16560000000 | 1032336000 |
| Friday, January 1, 2016 | 19427000000 | 1702177000 |
| Sunday, January 1, 2017 | 20776000000 | 2488652000 |
| Monday, January 1, 2018 | 22561000000 | 3047597000 |
| Tuesday, January 1, 2019 | 26145000000 | 4162821000 |
| Wednesday, January 1, 2020 | 42518000000 | 6205683000 |
| Friday, January 1, 2021 | 46385000000 | 7574400000 |
| Saturday, January 1, 2022 | 46159000000 | 8930700000 |
| Sunday, January 1, 2023 | 45006000000 | 9869200000 |
| Monday, January 1, 2024 | 48300000000 | 11020100000 |
Cracking the code
In the competitive landscape of pharmaceuticals, Bristol-Myers Squibb Company and Vertex Pharmaceuticals Incorporated have showcased remarkable revenue trajectories over the past decade. From 2014 to 2023, Bristol-Myers Squibb's revenue surged by approximately 183%, peaking in 2021 with a 193% increase from its 2014 figures. Meanwhile, Vertex Pharmaceuticals demonstrated an impressive growth of over 1600%, reflecting its dynamic expansion in the biotech sector.
Bristol-Myers Squibb's revenue growth was particularly notable between 2019 and 2020, with a 63% increase, likely driven by strategic acquisitions and product launches. On the other hand, Vertex Pharmaceuticals saw its most significant leap between 2018 and 2019, with a 37% rise, underscoring its innovation in cystic fibrosis treatments.
These trends highlight the evolving strategies and market positions of these industry leaders, offering valuable insights into their financial health and future potential.
Breaking Down Revenue Trends: Johnson & Johnson vs Bristol-Myers Squibb Company
Gross Profit Trends Compared: Bristol-Myers Squibb Company vs Vertex Pharmaceuticals Incorporated
Bristol-Myers Squibb Company vs Ascendis Pharma A/S: Annual Revenue Growth Compared
Revenue Showdown: Bristol-Myers Squibb Company vs Amneal Pharmaceuticals, Inc.
Revenue Showdown: Bristol-Myers Squibb Company vs Viridian Therapeutics, Inc.
Who Generates More Revenue? Bristol-Myers Squibb Company or MiMedx Group, Inc.
Breaking Down Revenue Trends: Gilead Sciences, Inc. vs Vertex Pharmaceuticals Incorporated
Comparing Revenue Performance: Vertex Pharmaceuticals Incorporated or Takeda Pharmaceutical Company Limited?
Revenue Insights: Vertex Pharmaceuticals Incorporated and BeiGene, Ltd. Performance Compared
Vertex Pharmaceuticals Incorporated or Amphastar Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Galapagos NV
Revenue Showdown: Vertex Pharmaceuticals Incorporated vs MiMedx Group, Inc.